What influences adherence to guidance for postoperative instillation of intravesical chemotherapy to patients with bladder cancer?

被引:12
作者
Dunsmore, Jennifer [1 ]
Duncan, Eilidh [2 ]
Mariappan, Paramananthan [3 ]
de Bruin, Marijn [4 ,5 ]
MacLennan, Sara [1 ]
Dimitropoulos, Konstantinos [1 ,6 ]
Kasivisvanathan, Veeru [7 ]
Mostafid, Hugh [8 ]
Briganti, Alberto [9 ,10 ,11 ]
N'Dow, James [1 ,6 ,11 ]
MacLennan, Steven [1 ]
机构
[1] Univ Aberdeen, Acad Urol Unit, Inst Appl Hlth Sci, Aberdeen, Scotland
[2] Univ Aberdeen, Hlth Serv Res Unit, Inst Appl Hlth Sci, Aberdeen, Scotland
[3] Univ Edinburgh, Western Gen Hosp, Edinburgh Bladder Canc Surg, Dept Urol, Edinburgh, Midlothian, Scotland
[4] Radboudumc, IQ Healthcare, Radboud Inst Hlth Sci, Nijmegen, Netherlands
[5] Univ Aberdeen, Inst Appl Hlth Sci, Aberdeen Hlth Psychol Grp, Aberdeen, Scotland
[6] Aberdeen Royal Infirm, Dept Urol, NHS Grampian, Aberdeen, Scotland
[7] UCL, London, England
[8] Royal Surrey Cty Hosp, Dept Urol, Guildford, Surrey, England
[9] IRCCS Osped San Raffaele, Milan, Italy
[10] Univ Vita Salute San Raffaele, Milan, Italy
[11] European Assoc, Urol Guidelines Off, Arnhem, Netherlands
基金
英国惠康基金;
关键词
guideline adherence; implementation science; non‐ muscle‐ invasive bladder cancer; Theoretical Domains Framework; #BladderCancer; #blcsm; #uroonc; THEORETICAL DOMAINS FRAMEWORK; BEHAVIOR-CHANGE; TRANSURETHRAL RESECTION; QUALITY; EPIDEMIOLOGY; GUIDELINES; CARCINOMA; GRADE;
D O I
10.1111/bju.15336
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective To understand the barriers and facilitators to single instillation of intravesical chemotherapy (SI-IVC) use after resection of non-muscle-invasive bladder cancer (NMIBC) in Scotland and England using a behavioural theory-informed approach. Subjects and Methods In a cross-sectional descriptive study of practices at seven hospitals, we investigated care pathways, policies, and interviewed 30 urology staff responsible for SI-IVC. We used the Theoretical Domains Framework (TDF) to organise our investigation and conducted deductive thematic analyses, while inductively coding emergent beliefs. Results Barriers to SI-IVC were present at different organisational levels and professional roles. In four hospitals, there was a policy to not instil SI-IVC in theatre. Six hospitals' staff reported delays in mitomycin C (MMC) ordering and/or local storage. Lack of training, skills and perceived workload affected motivation. Facilitators included access to modern instilling devices (four hospitals) and incorporating reminders in operation proforma (four hospitals). Performance targets (with audit and feedback) within a national governance framework were present in Scotland but not England. Differences in coordinated leadership, sharing best practices, and disliking being perceived as underperforming, were evident in Scotland. Conclusions High-certainty evidence shows that SI-IVC, such as MMC, after NMIBC resection reduces recurrences. This evidence underpins international guidance. The number of eligible patients receiving SI-IVC is variable indicating suboptimal practice. Improving SI-IVC adherence requires modifications to theatre instilling policies, delivery and storage of MMC, staff training, and documentation. Centralising care, with bladder cancer expert leadership and best practices sharing with performance targets, likely led to improvements in Scotland. National quality improvement, incorporating audit and feedback, with additional implementation strategies targeted to professional role could improve adherence and patient outcomes elsewhere. This process should be controlled to clarify implementation intervention effectiveness.
引用
收藏
页码:225 / 235
页数:11
相关论文
共 43 条
  • [1] [Anonymous], 2020, NVivoqualitative data analysis software
  • [2] Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
    Antoni, Sebastien
    Ferlay, Jacques
    Soerjomataram, Isabelle
    Znaor, Ariana
    Jemal, Ahmedin
    Bray, Freddie
    [J]. EUROPEAN UROLOGY, 2017, 71 (01) : 96 - 108
  • [3] A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems
    Atkins, Lou
    Francis, Jill
    Islam, Rafat
    O'Connor, Denise
    Patey, Andrea
    Ivers, Noah
    Foy, Robbie
    Duncan, Eilidh M.
    Colquhoun, Heather
    Grimshaw, Jeremy M.
    Lawton, Rebecca
    Michie, Susan
    [J]. IMPLEMENTATION SCIENCE, 2017, 12
  • [4] European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)-2019 Update
    Babjuk, Marko
    Burger, Maximilian
    Comperat, Eva M.
    Gontero, Paolo
    Mostafid, A. Hugh
    Palou, Joan
    van Rhijn, Bas W. G.
    Roupret, Morgan
    Shariat, Shahrokh F.
    Sylvester, Richard
    Zigeuner, Richard
    Capoun, Otakar
    Cohen, Daniel
    Dominguez Escrig, Jose Luis
    Hernandez, Virginia
    Peyronnet, Benoit
    Seisen, Thomas
    Soukup, Viktor
    [J]. EUROPEAN UROLOGY, 2019, 76 (05) : 639 - 657
  • [5] Bryman, 2008, SOCIAL RESERACH METH
  • [6] Epidemiology and Risk Factors of Urothelial Bladder Cancer
    Burger, Maximilian
    Catto, James W. F.
    Dalbagni, Guido
    Grossman, H. Barton
    Herr, Harry
    Karakiewicz, Pierre
    Kassouf, Wassim
    Kiemeney, Lambertus A.
    La Vecchia, Carlo
    Shariat, Shahrokh
    Lotan, Yair
    [J]. EUROPEAN UROLOGY, 2013, 63 (02) : 234 - 241
  • [7] Understanding the Use of Immediate Intravesical Chemotherapy for Patients with Bladder Cancer
    Burks, Frank N.
    Liu, Alice B.
    Suh, Ronald S.
    Schuster, Timothy G.
    Bradford, Timothy
    Moylan, Don A.
    Knapp, Peter M.
    Murtagh, Daniel S.
    Dunn, Rodney L.
    Montie, James E.
    Miller, David C.
    [J]. JOURNAL OF UROLOGY, 2012, 188 (06) : 2108 - 2113
  • [8] Cancer Research UK (CRUK), 2020, BLADD CANC INC STAT
  • [9] Validation of the theoretical domains framework for use in behaviour change and implementation research
    Cane, James
    O'Connor, Denise
    Michie, Susan
    [J]. IMPLEMENTATION SCIENCE, 2012, 7
  • [10] Perioperative Intravesical Chemotherapy for Patients With Non-Muscle-invasive Bladder Cancer: Understanding the Extent of and Sources of Variation in Guideline- recommended Use
    Check, Devon K.
    Aaronson, David S.
    Nielsen, Matthew E.
    Lee, Valerie S.
    Ergas, Isaac J.
    Roh, Janise M.
    Kushi, Lawrence H.
    Tang, Li
    Kwan, Marilyn L.
    [J]. UROLOGY, 2019, 124 : 107 - 112